Analytical Data
-
基因名
EDA2R
- Application
-
别名
EDA2R；TNFRSF27；XEDAR；Tumor necrosis factor receptor superfamily member 27
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9HAV5
-
表达区间
1-139aa
-
氨基酸序列
ADPMDCQENE YWDQWGRCVT CQRCGPGQEL SKDCGYGEGG DAYCTACPPR RYKSSWGHHR CQSCITCAVI NRVQKVNCTA TSNAVCGDCL PRFYRKTRIG GLQDQECIPC TKQTPTSEVQ CAFQLSLVEA DAPTVPPQEA TLEPKSCDKT HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SRDELTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGKHHHHHH
-
分子量
43 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of EDA2R recombinant proteins is rooted in the importance of endocytic pathways and their roles in cellular functions. EDA2R (Endothelial Differentiation-Related Factor 2 Receptor) is a receptor that is predominantly expressed in endothelial cells and is implicated in various physiological processes, including vasculogenesis and angiogenesis. Recent research has highlighted its significance in the context of diseases such as cancer and cardiovascular disorders, wherein EDA2R may influence tumor growth and blood vessel formation. Recombinant protein technology enables the production of EDA2R in higher quantities and purity, facilitating in-depth functional studies to elucidate its mechanisms and interactions. Investigating the recombinant form of EDA2R can also assist in the development of potential therapeutic interventions, as modulators of EDA2R signaling pathways could provide novel strategies for treating associated diseases. The understanding of EDA2R's structure-function relationships through recombinant protein studies may reveal critical insights into its role in disease pathology and pave the way for future biomedical applications. Overall, the exploration of EDA2R as a recombinant protein encapsulates a significant intersection of molecular biology, therapeutic development, and translational research focused on improving human health outcomes.
